Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT03790332 · COMPLETED
Trial details
- NCT number
- NCT03790332
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2025-10-09
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.